Lindsay A. Abraham, JD, CIP
Regulatory Chair Director
Biography
Lindsay Abraham joined Western IRB (WIRB) in 2010 and is currently the Regulatory Chair Director at WCG IRB.
Ms. Abraham has co-authored several White Papers on topics related to IRB work, and both chairs Board meetings and provides guidance to the Board and clients regarding the interpretation of federal and state laws pertaining to IRB operations and functions. Ms. Abraham also presents education and training courses for Board members and staff.
Prior to joining WIRB, Ms. Abraham practiced in the field of family law, and holds a Juris Doctorate from Seattle University School of Law.
Latest insights by Lindsay
Regulatory Compliance
How WCG Is Preparing for FDA Harmonization with the Common Rule
Blog Posts
Ethics in Clinical Research
If My Study Includes Approved Drugs, When Do the Risks of Those Drugs Need to Be Disclosed in the Consent Form?
Blog Posts
Ethics in Clinical Research
Post Study Activities Requiring IRB Review
Blog Posts
Ethics in Clinical Research
What are the requirements for notifications of study closure at research sites?
Blog Posts
Participant Recruitment
Can you use patient Electronic Health Records to identify and recruit subjects?
Blog Posts
FDA & ICH
What documentation needs to be submitted to the IRB for an IND exemption request?
Blog Posts
Ethics in Clinical Research
Do parents need to accompany adolescents at each research-related office visit?
Blog Posts
Series: Ask the IRB & IBC Experts
Should Consent Form updates be aligned with Investigator Brochure updates, or wait for next Protocol amendment?
Blog PostsQuestions on the FDA’s 30-Day IND Review Period and IRB Approval
Blog Posts
Series: Ask the IRB & IBC Experts